Načítá se...
A predictive model for carcinogenesis in patients with chronic hepatitis B undergoing entecavir therapy and its validation
We created a model to predict the development of liver carcinogenesis in patients with chronic hepatitis B (CHB) undergoing entecavir (ETV) therapy and to validate the accuracy using an independent dataset. A total of 328 CHB subjects were analyzed. Subjects were randomly assigned into 2 groups: the...
Uloženo v:
| Vydáno v: | Medicine (Baltimore) |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Wolters Kluwer Health
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5023923/ https://ncbi.nlm.nih.gov/pubmed/27603400 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000004832 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|